Clinical Trials in South Korea

Active recruiting clinical trials with sites in South Korea. Select a condition below to see detailed trial listings.

Total Trials: 162 // Recruiting: 162 // Updated: Daily

South Korea currently has 162 clinical trials with at least one registered site in the country, of which 162 are actively recruiting participants. The most studied conditions at South Korea sites are Coronary Artery Disease, Ovarian Cancer, Breast Cancer, reflecting where local investigators and sponsors are concentrating enrolment.

Studies are led by sponsors including Seoul National University Hospital, Samsung Medical Center, Yonsei University. By stage, active South Korea trials break down as Phase 1 (20), Phase 2 (33), Phase 3 (9), Phase 4 (7). All figures update daily from ClinicalTrials.gov — select a condition below for full listings, eligibility and site contacts.

Top Conditions in South Korea

Coronary Artery Disease 8 Ovarian Cancer 5 Breast Cancer 5 Non-small Cell Lung Cancer 3 Shoulder Pain 2 Endometrial Cancer 2 Fallopian Tube Cancer 2 Peritoneal Cancer 2 Acute Myeloid Leukemia 2 Ulcerative Colitis 2 Crohn's Disease 2 Percutaneous Coronary Intervention 2 Myocardial Infarction 2 Prostate Cancer 2 Advanced Solid Tumor 2 Stroke 2 Colorectal Cancer 2 Type 2 Diabetes 2 Hypertension 2 Hepatocellular Carcinoma 2

All Countries → All Trials →

Other Countries in This Region

🇦🇺Australia 🇯🇵Japan

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology